DSM Forms 50-50 Joint Venture With Sinochem To Crack Into China's Restricted Anti-Infectives Market
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Netherlands-based Royal DSM announced Dec. 17 that it reached an agreement with Sinochem Group, one of China's biggest central state-owned enterprises, to form a global 50-50 joint venture for anti-infectives. The two companies expect to close the transaction in Q2 2011
You may also be interested in...
DSM In India Gets Neighborly With Nutritional Ingredient Customers
The Dutch conglomerate DSM will open a dietary supplements manufacturing site in India, where the company forecasts strong growth. While DSM currently distributes ingredients from plants in other countries to India, the facility will provide its customers quicker lead times for customized nutrient blends.
DSM In India Gets Neighborly With Nutritional Ingredient Customers
The Dutch conglomerate DSM will open a dietary supplements manufacturing site in India, where the company forecasts strong growth. While DSM currently distributes ingredients from plants in other countries to India, the facility will provide its customers quicker lead times for customized nutrient blends.
Nutrition Giant DSM Unveils New Indian Site To Gain Local Edge
Dutch conglomerate DSM has established a brand new dietary supplements manufacturing site in India. The company forecasts strong growth in the segment, and the new unit, which will replace imports, is preparing for quicker lead times and localized solutions.